Does DENOSUMAB Cause Hyperuricaemia? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hyperuricaemia have been filed in association with DENOSUMAB (Bilprevda). This represents 0.0% of all adverse event reports for DENOSUMAB.
13
Reports of Hyperuricaemia with DENOSUMAB
0.0%
of all DENOSUMAB reports
3
Deaths
5
Hospitalizations
How Dangerous Is Hyperuricaemia From DENOSUMAB?
Of the 13 reports, 3 (23.1%) resulted in death, 5 (38.5%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Hyperuricaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Hyperuricaemia?
RITUXIMAB (130)
PREDNISONE (118)
RIBAVIRIN (116)
TACROLIMUS (116)
VENETOCLAX (115)
FUROSEMIDE (100)
ALLOPURINOL (94)
RUXOLITINIB (92)
CYCLOPHOSPHAMIDE (91)
DEXAMETHASONE (87)
Which DENOSUMAB Alternatives Have Lower Hyperuricaemia Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE